5375 related articles for article (PubMed ID: 3942687)
21. Effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent.
Robins EJ; Breathnach AS; Bashin YP; Ethridge L; Nazzaro-Porro M; Passi S; Picardo M
J Invest Dermatol; 1986 Aug; 87(2):293-4. PubMed ID: 3734479
[No Abstract] [Full Text] [Related]
22. Hyperpigmentary disorders--mechanisms of action. Effect of azelaic acid on melanoma and other tumoral cells in culture.
Breathnach AS; Robins EJ; Nazzaro-Porro M; Passi S; Picardo M
Acta Derm Venereol Suppl (Stockh); 1989; 143():62-6. PubMed ID: 2672685
[TBL] [Abstract][Full Text] [Related]
23. Azelaic acid vs. placebo: effects on normal human keratinocytes and melanocytes. Electron microscopic evaluation after long-term application in vivo.
Mayer-da Silva A; Gollnick H; Imcke E; Orfanos CE
Acta Derm Venereol; 1987; 67(2):116-22. PubMed ID: 2438874
[TBL] [Abstract][Full Text] [Related]
24. Observations on cell kinetics and viability of a human melanoma cell line exposed to dicarboxylic acids in tissue culture.
Breathnach AS; Robins EJ; Bhasin Y; Ethridge L; Nazzaro-Porro M; Passi S; Picardo M
Histol Histopathol; 1986 Jul; 1(3):235-9. PubMed ID: 2980117
[TBL] [Abstract][Full Text] [Related]
25. Differences in subcellular distribution of catechol-O-methyltransferase and tyrosinase in malignant melanoma.
Shibata T; Pavel S; Smit NP; Mishima Y
J Invest Dermatol; 1993 Feb; 100(2 Suppl):222S-225S. PubMed ID: 8433011
[TBL] [Abstract][Full Text] [Related]
26. A role for tyrosinase-related protein 1 in 4-tert-butylphenol-induced toxicity in melanocytes: Implications for vitiligo.
Manga P; Sheyn D; Yang F; Sarangarajan R; Boissy RE
Am J Pathol; 2006 Nov; 169(5):1652-62. PubMed ID: 17071589
[TBL] [Abstract][Full Text] [Related]
27. Anti-melanogenic effects of resveratryl triglycolate, a novel hybrid compound derived by esterification of resveratrol with glycolic acid.
Park S; Seok JK; Kwak JY; Choi YH; Hong SS; Suh HJ; Park W; Boo YC
Arch Dermatol Res; 2016 Jul; 308(5):325-34. PubMed ID: 27059716
[TBL] [Abstract][Full Text] [Related]
28. Ultrastructural aspects of melanization of hamster Ab amelanotic melanoma in primary cell culture.
Bomirski A; Słomiński A
Acta Derm Venereol; 1986; 66(6):520-3. PubMed ID: 2433873
[TBL] [Abstract][Full Text] [Related]
29. Melanosomal defects in melanocytes from mice lacking expression of the pink-eyed dilution gene: correction by culture in the presence of excess tyrosine.
Rosemblat S; Sviderskaya EV; Easty DJ; Wilson A; Kwon BS; Bennett DC; Orlow SJ
Exp Cell Res; 1998 Mar; 239(2):344-52. PubMed ID: 9521852
[TBL] [Abstract][Full Text] [Related]
30. An inhibitory mechanism of action of a novel syringic-acid derivative on α-melanocyte-stimulating hormone (α-MSH)-induced melanogenesis.
Jeong YJ; Lee JY; Park J; Park SN
Life Sci; 2017 Dec; 191():52-58. PubMed ID: 28993145
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of Asterina pectinifera extracts on melanin biosynthesis through tyrosinase activity.
Jeong MH; Yang KM; Kim JK; Nam BH; Kim GY; Lee SW; Seo SY; Jo WS
Int J Mol Med; 2013 Jan; 31(1):205-12. PubMed ID: 23151809
[TBL] [Abstract][Full Text] [Related]
32. Expression and ultrastructural localization of HMB-45 antigen.
Kikuchi A; Shimizu H; Nishikawa T
Br J Dermatol; 1996 Sep; 135(3):400-5. PubMed ID: 8949433
[TBL] [Abstract][Full Text] [Related]
33. Extracellular matrix modulates the function of human melanocytes but not melanoma cells.
Ranson M; Posen S; Mason RS
J Cell Physiol; 1988 Aug; 136(2):281-8. PubMed ID: 3137234
[TBL] [Abstract][Full Text] [Related]
34. Antimitochondrial effect of saturated medium chain length (C8-C13) dicarboxylic acids.
Passi S; Picardo M; Nazzaro-Porro M; Breathnach A; Confaloni AM; Serlupi-Crescenzi G
Biochem Pharmacol; 1984 Jan; 33(1):103-8. PubMed ID: 6704136
[TBL] [Abstract][Full Text] [Related]
35. Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells.
Parsons PG; Hansen C; Fairlie DP; West ML; Danoy PA; Sturm RA; Dunn IS; Pedley J; Ablett EM
Biochem Pharmacol; 1997 Jun; 53(11):1719-24. PubMed ID: 9264325
[TBL] [Abstract][Full Text] [Related]
36. Isolation and characterization of tyrosinase inhibitors and their differential action on melanogenic subcellular compartments in amelanotic and melanomas.
Imokawa G; Mishima Y
Br J Dermatol; 1980 Dec; 103(6):625-33. PubMed ID: 6779849
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of the water-soluble polymer-wrapped derivative of fullerene on UVA-induced melanogenesis via downregulation of tyrosinase expression in human melanocytes and skin tissues.
Xiao L; Matsubayashi K; Miwa N
Arch Dermatol Res; 2007 Aug; 299(5-6):245-57. PubMed ID: 17333222
[TBL] [Abstract][Full Text] [Related]
38. KUVA (khellin plus ultraviolet A) stimulates proliferation and melanogenesis in normal human melanocytes and melanoma cells in vitro.
Carlie G; Ntusi NB; Hulley PA; Kidson SH
Br J Dermatol; 2003 Oct; 149(4):707-17. PubMed ID: 14616361
[TBL] [Abstract][Full Text] [Related]
39. Effect of azelaic acid on human malignant melanoma.
Nazzaro-Porro M; Passi S; Zina G; Bernengo A; Breathnach A; Gallagher S; Morpurgo G
Lancet; 1980 May; 1(8178):1109-11. PubMed ID: 6103442
[TBL] [Abstract][Full Text] [Related]
40. Selective cytotoxicity of N-acetyl-4-S-cysteaminylphenol on follicular melanocytes of black mice.
Wong M; Jimbow K
Br J Dermatol; 1991 Jan; 124(1):56-61. PubMed ID: 1993146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
